EUROPE SEQUENCING REAGENTS MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

EUROPE SEQUENCING REAGENTS MARKET 2021-2028

Market by Application, Reagent Type, Technology, Industry Verticals, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s report, the sequencing reagents market in Europe is anticipated to witness growth at a compound annual growth rate of 13.00% during the estimated years of 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries studied in this market comprise:

•        The United Kingdom

•        Spain

•        Germany

•        Italy

•        France

•        Russia

•        Rest of Europe

The market’s growth in the region is mainly due to the growth of biotechnology and government initiatives to increase R&D activities. Further, the rising prevalence of cancer and decreasing costs of genetic sequencing is estimated to surge the demand for sequencing reagents significantly over the estimated phase.

Germany is anticipated to emerge as the largest contributor to the sequencing reagents market. The country is among the leading hubs for biotechnology. Moreover, there has been substantial development in industrial biotechnology over the past years. Besides, the country is engaged in enhancing research and development by collaborating with various international organizations. For instance, the German Federal Government launched an ‘India and Germany – Strategic Partners for Innovation’ campaign. This step is anticipated to facilitate R&D collaborations between the Indian and German R&D institutes. Hence, such developments support the growth of the sequencing reagents market across the country.

The studied market in France is supported by the increasing funding in research and development activities. Moreover, the investments in research and developments relating to cancer and autoimmune diseases are estimated to drive the market’s growth. Additionally, several companies are adopting organic and inorganic materials for market development. For instance, MGI signed an agreement with the Health Ministry of France to offer equipment and material to enable COVID-19 testing across the country. Hence, these factors are estimated to open new avenues for the sequencing reagents market.

Merck KGAA is a pharmaceutical company operating in the chemical, pharmaceutical, and life science industries. It has operations across 67 nations, with around 72 manufacturing sites. Additionally, the company’s product line entails liquid crystals, life science and performance chemicals, over-the-counter medicines, and biopharmaceuticals, among others. EMD Serono is the company’s biopharmaceutical business division. Merck serves a wide client base, with headquarters in Darmstadt, Germany. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE SEQUENCING REAGENTS MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET

2.2. KEY INSIGHTS

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. SUPPLY CHAIN OUTLOOK

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. KEY STRATEGIC DEVELOPMENTS

2.7.1. CONTRACTS AND PARTNERSHIPS

2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

2.7.3. ACQUISITIONS & MERGERS

2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS

2.8. MARKET DRIVERS

2.8.1. ONGOING RESEARCH IN GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES

2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES

2.9. MARKET CHALLENGES

2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY

2.10. MARKET OPPORTUNITIES

2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS

2.10.2. GROWING DEMAND FOR THIRD-GENERATION SEQUENCING

3. EUROPE SEQUENCING REAGENTS MARKET - BY APPLICATION

3.1. ONCOLOGY

3.2. CLINICAL INVESTIGATION

3.3. AGRI GENOMICS AND FORENSICS

3.4. REPRODUCTIVE HEALTH

3.5. OTHER APPLICATIONS

4. EUROPE SEQUENCING REAGENTS MARKET - BY REAGENT TYPE

4.1. SEQUENCING KITS

4.2. CONTROL KITS

4.3. LIBRARY KITS

4.4. TEMPLATE KITS

4.5. OTHER REAGENT TYPES

5. EUROPE SEQUENCING REAGENTS MARKET - BY TECHNOLOGY

5.1. NEXT-GENERATION SEQUENCING

5.2. SANGER SEQUENCING

5.3. THIRD-GENERATION SEQUENCING

6. EUROPE SEQUENCING REAGENTS MARKET - BY INDUSTRY VERTICALS

6.1. RESEARCH INSTITUTES

6.2. HOSPITALS AND CLINICS

6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

6.4. OTHER INDUSTRY VERTICALS

7. EUROPE SEQUENCING REAGENTS MARKET – COUNTRY OUTLOOK

7.1. COUNTRY ANALYSIS

7.1.1. GERMANY

7.1.2. FRANCE

7.1.3. THE UNITED KINGDOM

7.1.4. ITALY

7.1.5. RUSSIA

7.1.6. SPAIN

7.1.7. REST OF EUROPE

8. COMPANY PROFILE

8.1. AGILENT TECHNOLOGIES INC

8.2. ASURAGEN INC

8.3. BGI GENOMICS

8.4. BIO RAD LABORATORIES INC

8.5. F HOFFMANN LA ROCHE

8.6. FLUIDIGM CORPORATION

8.7. ILLUMINA INC

8.8. LGC BIOSEARCH TECHNOLOGIES

8.9. MERCK KGAA

8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC

8.11. PERKINELMER INC

8.12. QIAGEN NV

8.13. TAKARA BIO INC

8.14. THERMO FISHER SCIENTIFIC INC

8.15. TRILINK BIOTECHNOLOGIES INC

9. RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1. OBJECTIVES OF STUDY

9.1.2. SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1. PRIMARY DATA SOURCES

9.2.2. SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1. EVALUATION OF PROPOSED MARKET

9.3.2. IDENTIFICATION OF DATA SOURCES

9.3.3. ASSESSMENT OF MARKET DETERMINANTS

9.3.4. DATA COLLECTION

9.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       EUROPE SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       LIST OF CONTRACTS AND PARTNERSHIPS

TABLE 4:       LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

TABLE 5:       LIST OF ACQUISITIONS & MERGERS

TABLE 6:       LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 7:       EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 8:       EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 9:       EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 10:     EUROPE SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

TABLE 11:     EUROPE SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     EUROPE SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 2:     EUROPE SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 3:     EUROPE SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)

FIGURE 4:     EUROPE SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)

FIGURE 5:     EUROPE SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)

FIGURE 6:     EUROPE SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 7:     EUROPE SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)

FIGURE 8:     EUROPE SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)

FIGURE 9:     EUROPE SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)

FIGURE 10:  EUROPE SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)

FIGURE 11:  EUROPE SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)

FIGURE 12:  EUROPE SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)

FIGURE 13:  EUROPE SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)

FIGURE 14:  EUROPE SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 15:  EUROPE SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 16:  EUROPE SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 17:  EUROPE SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)

FIGURE 18:  EUROPE SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 19:  EUROPE SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 20:  EUROPE SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 21:  EUROPE SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

FIGURE 22:  GERMANY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  FRANCE SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

FIGURE 24:  UNITED KINGDOM SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

FIGURE 25:  ITALY SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

FIGURE 26:  RUSSIA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

FIGURE 27:  SPAIN SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

FIGURE 28:  REST OF EUROPE SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;